Compositions of Erenumab and their uses

MA52202AUndetermined Publication Date: 2021-02-17AMGEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA52202
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-04-02
Filing Date
2019-04-01
Publication Date
2021-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.